Themis Medicare Limited: Trading Window Closes April 1, 2026 for Q4 FY26 Results
Themis Medicare Limited will close its trading window from April 1, 2026. The window will reopen 48 hours after the declaration of audited financial results for the quarter ending March 31, 2026. The board meeting date for considering these results will be announced later.
The closure of the trading window is a standard procedure before the declaration of financial results and does not directly impact the company's operations or financial performance.
The announcement is a routine regulatory disclosure regarding the closure of the trading window and does not contain any material financial or business updates.
Themis Medicare Limited has announced the closure of its trading window from Wednesday, April 1, 2026. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's own code of conduct for preventing insider trading.
The trading window will remain closed until 48 hours after the declaration of the audited financial results for the quarter ending March 31, 2026. The Board of Directors will consider these financial results, and the specific date for the board meeting will be communicated in due course.
What to do with a filing like this
Themis Medicare Limited filed this with the NSE as a statutory disclosure, categorised under trading window disclosure. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Themis Medicare Limited. Read the original for the full detail.